Bruker Daltonics Introduces Compass, an Intuitive Unified Software Environment for All Its Life-Science Mass Spectrometers.Business Editors/Health/Medical Writers Pittcon 2003 BIOWIRE2K ORLANDO, Fla.--(BUSINESS WIRE)--March 10, 2003 Compass gives a common user interface to all Bruker Daltonics life-science software At PittCon 2003, Bruker Daltonics Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on : BDAL BDAL Battle Doll Angelic Layer (game) ) today announces Compass(TM), a new unified software environment for intuitive mass spectrometric instrument control and data processing, as well as for powerful chemoinformatics and bioinformatics analysis software. In a modern life-science laboratory, users often need to acquire and process data from several different advanced mass spectrometers, such as ion traps, FTMS See Fusion FTMS. systems, orthogonal API-TOF and MALDI-TOF MALDI-TOF Matrix Assisted Laser Desorption Ionization - Time of Flight instruments. Previously, the control and processing software of each instrument varied, depending on the mass spectrometry platform used and the type of dataset. Compass is designed to offer a unified look and feel for instrument control and processing. Compass provides tools to aid both novice and expert users to acquire and process datasets and interpret results efficiently on all Bruker Daltonics life-science systems. Within the Compass environment, specific modules are selected, depending on the instrument and applications needs. The Compass instrument control module has a simple graphical user interface graphical user interface (GUI) Computer display format that allows the user to select commands, call up files, start programs, and do other routine tasks by using a mouse to point to pictorial symbols (icons) or lists of menu choices on the screen as opposed to having to (GUI), featuring customized spectral and chromatographic displays, together with tabulated windows for tuning, calibration and setup of specific parameters such as MS/MS MS/MS Tandem Mass Spectroscopy MS/MS Multistage Mass Spectrometry conditions. For processing, the Compass capabilities incorporate and expand on the well-proven DA module. Additional tools allow processing of high mass accuracy datasets, generated from Bruker Daltonics MALDI-TOF, API-TOF and FTMS instruments. Elemental composition calculation, isotopic pattern comparisons and internal and external recalibration are included features. Automated or complex processing is supported through VBScripting. A ReportDesigner can create customized reports in different formats. All Compass data acquisition and processing modules will provide the necessary functions needed to work in compliance with FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. 21CFR CFR See: Cost and Freight , Part 11 requirements. Advanced Compass data interpretation uses additional chemo-/bioinformatics modules, depending on the applications requirements. Examples include QuantAnalysis, Biotools for protein sequence confirmation, RapiDeNovo for sequencing of peptides, MetaboliteTools for advanced comparison of different LC/MS LC/MS Liquid Chromatography/Mass Spectrometry datasets to pinpoint the presence of low levels of metabolites and predict the structures of the metabolites, and LibrarySearch for comparison of MS/MS spectra against reference spectra. ABOUT BRUKER DALTONICS Bruker Daltonics is a leading developer and provider of innovative life science tools based on mass spectrometry. For more information about Bruker Daltonics, please visit www.bdal.com or www.bdal.de CAUTIONARY STATEMENT Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to technological approaches, product development, manufacturing, market acceptance, cost and pricing of Bruker Daltonics' products, dependence on collaborative partners, suppliers, FDA and other regulatory approvals to the extent applicable, competition, the intellectual property of others, patent protection and litigation An action brought in court to enforce a particular right. The act or process of bringing a lawsuit in and of itself; a judicial contest; any dispute. When a person begins a civil lawsuit, the person enters into a process called litigation. and other risk factors discussed from time to time in Bruker Daltonics' reports or filings with the Securities and Exchange Commission. Bruker Daltonics expressly disclaims any obligation to update the information contained herein. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion